SEATTLE--(BUSINESS WIRE)--Juno Therapeutics, Inc. (Nasdaq: JUNO), a biopharmaceutical company focused on re-engaging the body’s immune system to revolutionize the treatment of cancer, today announced ...
It was a clear, calm night at Cape Canaveral. The Army, making its first attempt to shoot the moon, had spent weeks fussing over the Juno II, a 60-ton Jupiter IRBM with a spike of high-speed rockets ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback